Inability to walk, disequilibrium, incoherent speech, disorientation following the instillation of 1% cyclopentolate eyedrops: case report.
A 4-year-old boy, who had no prior history of convulsions, presented with inability to walk, disequilibrium, dysarthria (incoherent speech), and impaired cognition (disorientation) following the instillation of 1% cyclopentolate, a commonly used mydriatic in pediatric practice. This case demonstrates the uncommon, although serious, atropine-like adverse effect of cyclopentolate eyedrops in usual dosage in child.
Department of Pediatric Emergency, Gazi University Faculty of Medicine, Ankara, Turkey. oderinoz@gazi.edu.tr
Oksan
O
Derinoz
Anil
A
Er
D001338:Autonomic Fibers, Postganglionic / Q000187:drug effects; D002675:Child, Preschool; D018680:Cholinergic Antagonists / Q000008:administration & dosage / Q000009:adverse effects*; D003221:Confusion / Q000139:chemically induced*; D003519:Cyclopentolate / Q000008:administration & dosage / Q000009:adverse effects*; D003941:Diagnostic Techniques, Ophthalmological; D004401:Dysarthria / Q000139:chemically induced*; D004630:Emergencies; D020233:Gait Disorders, Neurologic / Q000139:chemically induced*; D006801:Humans; D008297:Male; D009184:Mydriatics / Q000008:administration & dosage / Q000009:adverse effects*; D009883:Ophthalmic Solutions; D004856:Postural Balance / Q000187:drug effects*; D012678:Sensation Disorders / Q000139:chemically induced*
D018680:Cholinergic Antagonists; D009184:Mydriatics; D009883:Ophthalmic Solutions; D003519:Cyclopentolate